J. Ainsa, C. Martin, M. Cabeza, F. De-la-cruz, and M. Mendiola, Construction of a family of Mycobacterium/Escherichia coli shuttle vectors derived from pAL5000 and pACYC184: their use for cloning an antibiotic-resistance gene from Mycobacterium fortuitum, Gene, vol.176, issue.1-2, pp.23-26, 1996.
DOI : 10.1016/0378-1119(96)00202-8

A. Banerjee, inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis, Science, vol.263, issue.5144, pp.227-230, 1994.
DOI : 10.1126/science.8284673

M. Biava, BM 212 and its Derivatives as a New Class of Antimycobacterial Active Agents, Current Medicinal Chemistry, vol.9, issue.21, pp.1859-1869, 2002.
DOI : 10.2174/0929867023368953

M. Biava, Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach, ChemMedChem, vol.18, issue.4, pp.593-598, 2011.
DOI : 10.1002/cmdc.201000526

E. Chan and M. Iseman, Multidrug-resistant and extensively drug-resistant tuberculosis: a review, Current Opinion in Infectious Diseases, vol.21, issue.6, pp.587-595, 2008.
DOI : 10.1097/QCO.0b013e328319bce6

S. Cole, Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature, vol.25, issue.6685, pp.537-544, 1998.
DOI : 10.1038/31159

D. Deidda, Bactericidal activities of the pyrrole derivative BM FIG 3 [ 14 C]BM212 accumulation by M. smegmatis wild-type and M. smegmatis MSMEG-GR12.5 cells. [ 14 C]BM212 was added to the cells at time zero, The results are the averages of data from three experiments, and error bars indicate standard deviations, 1998.

L. Rosa, berculosis strains, Antimicrob. Agents Chemother, vol.42, pp.3035-3037

P. Domenech, M. Reed, C. Barry, and . Iii, Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance, Infection and Immunity, vol.73, issue.6, pp.3492-3501, 2005.
DOI : 10.1128/IAI.73.6.3492-3501.2005

M. Donnelly-wu, W. Jacobs, . Jr, and G. Hatfull, Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria, Molecular Microbiology, vol.7, issue.3, pp.407-417, 1993.
DOI : 10.1007/BF00266145

W. Jacobs and . Jr, [25] Genetic systems for mycobacteria, Methods Enzymol, vol.204, pp.537-555, 1991.
DOI : 10.1016/0076-6879(91)04027-L

D. Jones, W. Taylor, and J. Thornton, A Model Recognition Approach to the Prediction of All-Helical Membrane Protein Structure and Topology, Biochemistry, vol.33, issue.10, pp.3038-3049, 1994.
DOI : 10.1021/bi00176a037

A. Lenaerts, M. Degroote, and I. Orme, Preclinical testing of new drugs for tuberculosis: current challenges, Trends in Microbiology, vol.16, issue.2, pp.48-54, 2008.
DOI : 10.1016/j.tim.2007.12.002

C. Lienhardt, A. Vernon, and M. Raviglione, New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes, Current Opinion in Pulmonary Medicine, vol.16, pp.186-193, 2010.
DOI : 10.1097/MCP.0b013e328337580c

K. Mdluli, Inhibition of a Mycobacterium tuberculosis -Ketoacyl ACP Synthase by Isoniazid, Science, vol.280, issue.5369, pp.1607-1610, 1998.
DOI : 10.1126/science.280.5369.1607

D. Payne, M. Gwynn, D. Holmes, and D. Pompliano, Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nature Reviews Drug Discovery, vol.293, issue.1, pp.29-40, 2007.
DOI : 10.1038/nrd2201

K. Poole, Efflux pumps as antimicrobial resistance mechanisms, Annals of Medicine, vol.58, issue.1, pp.162-176, 2007.
DOI : 10.1093/jac/dkl441

S. Ramaswamy and J. Musser, Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update, Tubercle and Lung Disease, vol.79, issue.1, pp.3-29, 1998.
DOI : 10.1054/tuld.1998.0002

G. Riccardi, M. Pasca, and S. Buroni, : drug resistance and future perspectives, Future Microbiology, vol.4, issue.5, pp.597-614, 2009.
DOI : 10.2217/fmb.09.20

D. Rozwarski, G. Grant, D. Barton, W. Jacobs, . Jr et al., Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis, Science, vol.279, issue.5347, pp.98-102, 1998.
DOI : 10.1126/science.279.5347.98

J. Sambrook and D. Russell, Molecular cloning: a laboratory manual, 2001.

W. Szybalski and V. Bryson, Genetic studies on microbial cross resistance to toxic agents. 1. Cross resistance of Escherichia coli to 15 antibiotics, J. Bacteriol, vol.64, pp.489-499, 1952.

M. Tullius, Discovery and characterization of a unique mycobacterial heme acquisition system, Proceedings of the National Academy of Sciences, vol.187, issue.4, pp.5051-5056, 2011.
DOI : 10.1128/JB.187.4.1238-1245.2005

P. Wyatt, I. Gilbert, K. Read, and A. Fairlamb, Target Validation: Linking Target and Chemical Properties to Desired Product Profile, Current Topics in Medicinal Chemistry, vol.11, issue.10, pp.1275-1283, 2011.
DOI : 10.2174/156802611795429185